- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06172881
Novel Multifocal Soft Contact Lens Study
April 25, 2024 updated by: Jennifer Fogt, Ohio State University
A single site, open label protocol will be used to evaluate the safety and quality of vision of a novel soft contact lens.
Habitual contact lens wearers will be asked to come to the study site for one visit.
Ocular health assessments and visual acuity will be completed with both the study lens and without.
Study Overview
Study Type
Interventional
Enrollment (Actual)
10
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Ohio
-
Columbus, Ohio, United States, 43210
- The Ohio State University College of Optometry
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Ability to give informed consent
- Any gender
- Any racial or ethnic origin
- 18 - 40 years of age
- Distance visual acuity with best corrected visual acuity of 20/25 with each eye
- Habitual soft contact lens wearer with myopia
- Good general health (defined by medication use that has not changed within the last month and the absence of medical conditions or treatments that are deemed confounding to the data as determined by the investigator).
Exclusion Criteria:
- Current or active ocular inflammation or infection as determined by the Investigator.
- Astigmatism > 0.75 D in either eye
- History of previous eye surgery
- Demonstration or history of corneal ectasia or keratoconus.
- Pregnant or lactating.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Distance Visual Acuity
Visual acuity will be measured while participant's wear study lenses.
|
A soft contact lens that will be worn only at the study visit.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Distance Visual Acuity
Time Frame: 1 day (This is a single visit study)
|
LogMAR typically ranges from -0.3 (20/10 vision on the Snellen chart) to 1 (20/200 vision).
Lower scores indicate better vision.
|
1 day (This is a single visit study)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Jennifer Fogt, OD, MS, The Ohio State University College of Optometry
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
December 14, 2023
Primary Completion (Actual)
January 12, 2024
Study Completion (Actual)
January 12, 2024
Study Registration Dates
First Submitted
November 29, 2023
First Submitted That Met QC Criteria
December 14, 2023
First Posted (Actual)
December 15, 2023
Study Record Updates
Last Update Posted (Actual)
May 1, 2024
Last Update Submitted That Met QC Criteria
April 25, 2024
Last Verified
April 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2023W0119
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
Yes
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Myopia
-
Tianjin Medical University Eye HospitalNot yet recruitingProgressive Myopia | Pediatric Myopia | Orthokeratology-related Myopia Progression
-
Shanghai General Hospital, Shanghai Jiao Tong University...Not yet recruitingMyopia | Myopia, ProgressiveChina
-
SightGlass Vision, Inc.Recruiting
-
University of FaisalabadCompletedRefractive Errors | Myopia | Progressive MyopiaPakistan
-
SightGlass Vision, Inc.RecruitingMyopia | Myopia Progression | Juvenile MyopiaUnited States
-
Shanghai Eye Disease Prevention and Treatment CenterEnrolling by invitationMyopia, Child Myopia ProgressionChina
-
He Eye HospitalNot yet recruiting
-
Zhongshan Ophthalmic Center, Sun Yat-sen UniversityActive, not recruiting
-
University Eye Hospital, FreiburgActive, not recruiting
-
University of BradfordUniversity of Huddersfield; CooperVision International Limited (CVIL)Enrolling by invitationMyopia, ProgressiveUnited Kingdom
Clinical Trials on Investigational Contact Lens
-
Bausch & Lomb IncorporatedCompleted
-
Johnson & Johnson Vision Care, Inc.Completed
-
Bausch & Lomb IncorporatedCompleted
-
Bausch & Lomb IncorporatedCompleted
-
Bausch & Lomb IncorporatedCompletedCorneal DeformityUnited States
-
Johnson & Johnson Vision Care, Inc.CompletedVisual AcuityUnited States
-
Johnson & Johnson Vision Care, Inc.CompletedVisual AcuityUnited States
-
CIBA VISIONCompletedAstigmatism | Myopia
-
Johnson & Johnson Vision Care, Inc.Completed